nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—ALB—focal segmental glomerulosclerosis	0.765	1	CbGaD
Diflunisal—SLC22A6—Cyclosporine—focal segmental glomerulosclerosis	0.137	1	CbGbCtD
Diflunisal—UGT1A8—kidney—focal segmental glomerulosclerosis	0.00828	0.226	CbGeAlD
Diflunisal—PTGS2—nephron—focal segmental glomerulosclerosis	0.00697	0.19	CbGeAlD
Diflunisal—SLC22A6—nephron tubule—focal segmental glomerulosclerosis	0.00443	0.121	CbGeAlD
Diflunisal—TTR—kidney—focal segmental glomerulosclerosis	0.0038	0.104	CbGeAlD
Diflunisal—SLC22A6—cortex of kidney—focal segmental glomerulosclerosis	0.00379	0.103	CbGeAlD
Diflunisal—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00344	0.0936	CbGeAlD
Diflunisal—PTGS2—endothelium—focal segmental glomerulosclerosis	0.00329	0.0895	CbGeAlD
Diflunisal—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.00259	0.122	CbGpPWpGaD
Diflunisal—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.0575	CcSEcCtD
Diflunisal—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.0506	CcSEcCtD
Diflunisal—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00158	0.0404	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00153	0.0721	CbGpPWpGaD
Diflunisal—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.0378	CcSEcCtD
Diflunisal—PTGS1—kidney—focal segmental glomerulosclerosis	0.00138	0.0377	CbGeAlD
Diflunisal—PTGS2—kidney—focal segmental glomerulosclerosis	0.00132	0.036	CbGeAlD
Diflunisal—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0312	CcSEcCtD
Diflunisal—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00122	0.0312	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00122	0.0572	CbGpPWpGaD
Diflunisal—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.0295	CcSEcCtD
Diflunisal—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0293	CcSEcCtD
Diflunisal—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.00103	0.0486	CbGpPWpGaD
Diflunisal—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.000986	0.0251	CcSEcCtD
Diflunisal—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.000969	0.0247	CcSEcCtD
Diflunisal—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.000931	0.0237	CcSEcCtD
Diflunisal—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.000885	0.0226	CcSEcCtD
Diflunisal—TTR—Retinoid metabolism and transport—LPL—focal segmental glomerulosclerosis	0.000874	0.0411	CbGpPWpGaD
Diflunisal—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000829	0.0211	CcSEcCtD
Diflunisal—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000822	0.021	CcSEcCtD
Diflunisal—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000822	0.021	CcSEcCtD
Diflunisal—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000804	0.0205	CcSEcCtD
Diflunisal—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000757	0.0193	CcSEcCtD
Diflunisal—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00073	0.0186	CcSEcCtD
Diflunisal—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000706	0.018	CcSEcCtD
Diflunisal—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000703	0.0179	CcSEcCtD
Diflunisal—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00065	0.0166	CcSEcCtD
Diflunisal—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000647	0.0165	CcSEcCtD
Diflunisal—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00064	0.0163	CcSEcCtD
Diflunisal—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000634	0.0162	CcSEcCtD
Diflunisal—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000621	0.0158	CcSEcCtD
Diflunisal—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000602	0.0154	CcSEcCtD
Diflunisal—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000592	0.0151	CcSEcCtD
Diflunisal—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.0143	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—COL4A4—focal segmental glomerulosclerosis	0.000549	0.0258	CbGpPWpGaD
Diflunisal—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000543	0.0138	CcSEcCtD
Diflunisal—TTR—FOXA2 and FOXA3 transcription factor networks—ALB—focal segmental glomerulosclerosis	0.000542	0.0255	CbGpPWpGaD
Diflunisal—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000538	0.0137	CcSEcCtD
Diflunisal—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000538	0.0137	CcSEcCtD
Diflunisal—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000532	0.025	CbGpPWpGaD
Diflunisal—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000527	0.0134	CcSEcCtD
Diflunisal—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.0133	CcSEcCtD
Diflunisal—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000513	0.0131	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—COL4A1—focal segmental glomerulosclerosis	0.000504	0.0237	CbGpPWpGaD
Diflunisal—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000487	0.0124	CcSEcCtD
Diflunisal—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.0123	CcSEcCtD
Diflunisal—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00048	0.0122	CcSEcCtD
Diflunisal—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000478	0.0122	CcSEcCtD
Diflunisal—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.0121	CcSEcCtD
Diflunisal—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000473	0.0223	CbGpPWpGaD
Diflunisal—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000468	0.0119	CcSEcCtD
Diflunisal—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000464	0.0118	CcSEcCtD
Diflunisal—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00046	0.0117	CcSEcCtD
Diflunisal—TTR—Diseases associated with visual transduction—LPL—focal segmental glomerulosclerosis	0.000446	0.021	CbGpPWpGaD
Diflunisal—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000443	0.0113	CcSEcCtD
Diflunisal—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00044	0.0112	CcSEcCtD
Diflunisal—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000437	0.0206	CbGpPWpGaD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.000428	0.0202	CbGpPWpGaD
Diflunisal—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000427	0.0109	CcSEcCtD
Diflunisal—TTR—Extracellular matrix organization—COL4A3—focal segmental glomerulosclerosis	0.000426	0.0201	CbGpPWpGaD
Diflunisal—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000425	0.0108	CcSEcCtD
Diflunisal—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000403	0.019	CbGpPWpGaD
Diflunisal—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000396	0.0101	CcSEcCtD
Diflunisal—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000386	0.00984	CcSEcCtD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000384	0.0181	CbGpPWpGaD
Diflunisal—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000381	0.00971	CcSEcCtD
Diflunisal—PTGS2—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000376	0.0177	CbGpPWpGaD
Diflunisal—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000368	0.00939	CcSEcCtD
Diflunisal—TTR—Non-integrin membrane-ECM interactions—TGFB1—focal segmental glomerulosclerosis	0.000356	0.0168	CbGpPWpGaD
Diflunisal—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000356	0.00907	CcSEcCtD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—focal segmental glomerulosclerosis	0.000345	0.0162	CbGpPWpGaD
Diflunisal—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000342	0.00872	CcSEcCtD
Diflunisal—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.00034	0.016	CbGpPWpGaD
Diflunisal—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000339	0.00865	CcSEcCtD
Diflunisal—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000339	0.00864	CcSEcCtD
Diflunisal—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000337	0.00859	CcSEcCtD
Diflunisal—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00032	0.00815	CcSEcCtD
Diflunisal—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.00029	0.0137	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—COL4A1—focal segmental glomerulosclerosis	0.000282	0.0133	CbGpPWpGaD
Diflunisal—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000267	0.0126	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	0.000234	0.011	CbGpPWpGaD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—focal segmental glomerulosclerosis	0.000228	0.0107	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.000223	0.0105	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PIAS1—focal segmental glomerulosclerosis	0.000209	0.00983	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—SPP1—focal segmental glomerulosclerosis	0.000187	0.00878	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.000179	0.00842	CbGpPWpGaD
Diflunisal—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000177	0.00834	CbGpPWpGaD
Diflunisal—Salicylic acid—ALB—focal segmental glomerulosclerosis	0.000164	0.533	CrCbGaD
Diflunisal—TTR—Extracellular matrix organization—FN1—focal segmental glomerulosclerosis	0.000156	0.00733	CbGpPWpGaD
Diflunisal—Flurbiprofen—ALB—focal segmental glomerulosclerosis	0.000144	0.467	CrCbGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—focal segmental glomerulosclerosis	0.000138	0.00649	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—MMP2—focal segmental glomerulosclerosis	0.000132	0.00622	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—SERPINE1—focal segmental glomerulosclerosis	0.00013	0.0061	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.000115	0.00544	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.000115	0.00543	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.000115	0.0054	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.000111	0.0052	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000109	0.00514	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.000102	0.00478	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—MMP9—focal segmental glomerulosclerosis	9.93e-05	0.00467	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	9.62e-05	0.00453	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CTGF—focal segmental glomerulosclerosis	9.61e-05	0.00452	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	9.34e-05	0.0044	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	9.22e-05	0.00434	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	9.17e-05	0.00432	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	9.17e-05	0.00431	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	9.15e-05	0.00431	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.85e-05	0.00417	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—NOS2—focal segmental glomerulosclerosis	8.61e-05	0.00405	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	8.58e-05	0.00404	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	8.58e-05	0.00404	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—TGFB1—focal segmental glomerulosclerosis	8.18e-05	0.00385	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	8.01e-05	0.00377	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	7.63e-05	0.00359	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	7.42e-05	0.00349	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	7.37e-05	0.00347	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	7.18e-05	0.00338	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	6.97e-05	0.00328	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—LPL—focal segmental glomerulosclerosis	6.66e-05	0.00314	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.46e-05	0.00304	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	6.31e-05	0.00297	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	6.27e-05	0.00295	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	6.17e-05	0.00291	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	5.99e-05	0.00282	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—AGT—focal segmental glomerulosclerosis	5.7e-05	0.00268	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.69e-05	0.00268	CbGpPWpGaD
Diflunisal—TTR—Disease—LPL—focal segmental glomerulosclerosis	5.67e-05	0.00267	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MMP9—focal segmental glomerulosclerosis	5.55e-05	0.00261	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	5.28e-05	0.00248	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.13e-05	0.00242	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	5.05e-05	0.00238	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.82e-05	0.00227	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	4.81e-05	0.00227	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	4.58e-05	0.00215	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.52e-05	0.00213	CbGpPWpGaD
Diflunisal—TTR—Disease—NOS2—focal segmental glomerulosclerosis	4.43e-05	0.00208	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	4.42e-05	0.00208	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—ALB—focal segmental glomerulosclerosis	4.37e-05	0.00206	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	4.27e-05	0.00201	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.15e-05	0.00195	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	4.09e-05	0.00193	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.97e-05	0.00187	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.94e-05	0.00186	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	3.83e-05	0.0018	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.76e-05	0.00177	CbGpPWpGaD
Diflunisal—TTR—Disease—SERPINE1—focal segmental glomerulosclerosis	3.73e-05	0.00175	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	3.7e-05	0.00174	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	3.65e-05	0.00172	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	3.55e-05	0.00167	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3.4e-05	0.0016	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.37e-05	0.00159	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	3.14e-05	0.00148	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.13e-05	0.00147	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.11e-05	0.00147	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	3.04e-05	0.00143	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.88e-05	0.00136	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.68e-05	0.00126	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.61e-05	0.00123	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.59e-05	0.00122	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.53e-05	0.00119	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.53e-05	0.00119	CbGpPWpGaD
Diflunisal—TTR—Disease—TGFB1—focal segmental glomerulosclerosis	2.35e-05	0.00111	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.33e-05	0.0011	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—LIPC—focal segmental glomerulosclerosis	2.29e-05	0.00108	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	2.24e-05	0.00106	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	2.2e-05	0.00104	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	2.17e-05	0.00102	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.17e-05	0.00102	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.06e-05	0.000968	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CTGF—focal segmental glomerulosclerosis	2.01e-05	0.000947	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	2e-05	0.000941	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.85e-05	0.000873	CbGpPWpGaD
Diflunisal—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	1.85e-05	0.00087	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.83e-05	0.000862	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	1.76e-05	0.000827	CbGpPWpGaD
Diflunisal—PTGS2—Disease—LPL—focal segmental glomerulosclerosis	1.67e-05	0.000784	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.65e-05	0.000776	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	1.63e-05	0.000766	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	1.5e-05	0.000707	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.5e-05	0.000706	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—LPL—focal segmental glomerulosclerosis	1.39e-05	0.000657	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NOS2—focal segmental glomerulosclerosis	1.3e-05	0.000612	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AGT—focal segmental glomerulosclerosis	1.19e-05	0.000562	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.16e-05	0.000544	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	1.15e-05	0.000543	CbGpPWpGaD
Diflunisal—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	1.13e-05	0.000531	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SERPINE1—focal segmental glomerulosclerosis	1.1e-05	0.000516	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	9.65e-06	0.000454	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ALB—focal segmental glomerulosclerosis	9.15e-06	0.000431	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TGFB1—focal segmental glomerulosclerosis	6.91e-06	0.000326	CbGpPWpGaD
